These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 14709515)

  • 41. [Bacteriological studies in the therapy of treatment-resistant staphylococcal infections with fusidic acid].
    Roser H
    Med Welt; 1967 May; 21():1325-9. PubMed ID: 5612546
    [No Abstract]   [Full Text] [Related]  

  • 42. Impetigo in a population over 8.5 years: incidence, fusidic acid resistance and molecular characteristics.
    Rørtveit S; Skutlaberg DH; Langeland N; Rortveit G
    J Antimicrob Chemother; 2011 Jun; 66(6):1360-4. PubMed ID: 21393202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survey, characterization and susceptibility to fusidic acid of Staphylococcus aureus in the Carmarthen area.
    El-Zimaity D; Kearns AM; Dawson SJ; Price S; Harrison GA
    J Antimicrob Chemother; 2004 Aug; 54(2):441-6. PubMed ID: 15269197
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fusidic acid resistance, mediated by fusB, in bovine coagulase-negative staphylococci.
    Yazdankhah SP; Asli AW; Sørum H; Oppegaard H; Sunde M
    J Antimicrob Chemother; 2006 Dec; 58(6):1254-6. PubMed ID: 17060340
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin.
    Woodford N; Afzal-Shah M; Warner M; Livermore DM
    J Antimicrob Chemother; 2008 Oct; 62(4):766-8. PubMed ID: 18567573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of fusidic acid-resistant Staphylococcus aureus isolates in the community of Casablanca (Morocco).
    Elazhari M; Abu-Quatouseh LF; Elhabchi D; Zerouali K; Dersi N; Saile R; Timinouni M; Becker K
    Int J Med Microbiol; 2012 Mar; 302(2):96-100. PubMed ID: 22197537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates.
    O'Neill AJ; Larsen AR; Henriksen AS; Chopra I
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3594-7. PubMed ID: 15328136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High levels of fusidic acid-resistant Staphylococcus aureus despite restrictions on antibiotic use.
    Mitra A; Mohanraj M; Shah M
    Clin Exp Dermatol; 2009 Mar; 34(2):136-9. PubMed ID: 18828847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of antibiotic resistance to orally administrable antibiotics in staphylococcal bone and joint infections in one of the largest university hospitals in Germany: is there a role for fusidic acid?
    Klein S; Nurjadi D; Eigenbrod T; Bode KA
    Int J Antimicrob Agents; 2016 Feb; 47(2):155-7. PubMed ID: 26774158
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Presence of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus in France.
    Laurent F; Tristan A; Croze M; Bes M; Meugnier H; Lina G; Vandenesch F; Etienne J
    J Antimicrob Chemother; 2009 Feb; 63(2):420-1; author reply 421. PubMed ID: 18978362
    [No Abstract]   [Full Text] [Related]  

  • 51. [Antibiotic resistance of Staphylococcus aureus isolated rom children. Comparative evolution between 1967 and 1972].
    Lelong M; Polaert J; Deroubaix P; Derambure S; Sorez JP; Vanlaeys R; Thelliez P; Hogedez G
    Lille Med; 1973 Apr; 18(4):433-7. PubMed ID: 4583469
    [No Abstract]   [Full Text] [Related]  

  • 52. Acquisition of antibiotic resistance by Staphylococcus aureus in skin patients.
    Naidoo J; Noble WC
    J Clin Pathol; 1978 Dec; 31(12):1187-92. PubMed ID: 748388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fusidic Acid: A Bacterial Elongation Factor Inhibitor for the Oral Treatment of Acute and Chronic Staphylococcal Infections.
    Fernandes P
    Cold Spring Harb Perspect Med; 2016 Jan; 6(1):a025437. PubMed ID: 26729758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In-vitro activity of fusidic acid against methicillin-resistant Staphylococcus aureus.
    Erdenizmenli M; Yapar N; Sengönül A; Yüce A; Cakir N; Yulug N
    J Chemother; 2004 Jun; 16(3):310-1. PubMed ID: 15330332
    [No Abstract]   [Full Text] [Related]  

  • 55. MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?
    Downey DG; Kidd TJ; Coulter C; Bell SC
    J Cyst Fibros; 2005 Sep; 4(3):205-7. PubMed ID: 16019268
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The decline of the impetigo epidemic caused by the epidemic European fusidic acid-resistant impetigo clone: an 11.5-year population-based incidence study from a community in Western Norway.
    Rørtveit S; Skutlaberg DH; Langeland N; Rortveit G
    Scand J Infect Dis; 2014 Dec; 46(12):832-7. PubMed ID: 25229166
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008).
    Castanheira M; Watters AA; Mendes RE; Farrell DJ; Jones RN
    J Antimicrob Chemother; 2010 Jul; 65(7):1353-8. PubMed ID: 20430787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increasing resistance to fusidic acid among clinical isolates of MRSA.
    Wang JT; Huang IW; Chang SC; Tan MC; Lai JF; Chen PY; Lauderdale TL
    J Antimicrob Chemother; 2017 Feb; 72(2):616-618. PubMed ID: 27733516
    [No Abstract]   [Full Text] [Related]  

  • 59. [Increase in rate of resistance to fusidic acid among Staphylococcus aureus isolates from patients admitted with atopic dermatitis].
    Peeters KA; Mascini EM; Blok HE; Sanders CJ
    Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2100-1. PubMed ID: 12448968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus.
    Unowsky J; Chandrasekar PH; DeLorenzo W; Levine DP
    Chemotherapy; 1986; 32(6):499-505. PubMed ID: 3492342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.